AXL and Alzheimer disease: As an inexpensive, well-established drug, metformin may represent an interesting immunomodulatory treatment option for patients with cirrhosis and no signs of AD, when AXL-expressing monocytes are frequent and the risk for metformin-associated lactic acidosis is low.